The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?-Reference-Cited by-同舟云学术

The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

Published:2007-01-17 Issue:2 Volume:11 Page:191-205
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Karagiannis Asterios,Mikhailidis Dimitri P,Athyros Vasilios G,Kakafika Anna I,Tziomalos Konstantinos,Liberopoulos Evangelos N,Florentin Matilda,Elisaf Moses

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.11.2.191

Reference205 articles.

1. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

2. Diagnosis and Management of the Metabolic Syndrome

3. Dyslipidaemia, Hypercoagulability and the Metabolic Syndrome

4. Prevalence of the Metabolic Syndrome Among US Adults

5. The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension in Metabolic Syndrome: Novel Insights;Current Hypertension Reviews;2020-02-13

2. Milk-Derived Tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) Enhance Insulin Sensitivity and Prevent Insulin Resistance in 3T3-F442A Preadipocytes;Journal of Agricultural and Food Chemistry;2018-08-30

3. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?;Current Vascular Pharmacology;2018-03-26

4. Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation;Diabetology & Metabolic Syndrome;2016-07-29

5. The mechanisms by which antidepressants may reduce coronary heart disease risk;BMC Cardiovascular Disorders;2015-08-01